Vern Norviel

Vern Norviel is a Partner Emeritus at Wilson Sonsini Goodrich & Rosati, a position held since January 2002. As Founder and Board Member of Neuvivo and an Advisor and Adjunct Professor at Stanford University School of Medicine since October 2023, Vern is involved in the innovative MTRAM program. Additional roles include serving as Strategic Advisor at the Ellison Institute of Technology Los Angeles, Special Adviser at Appletree Partners, and a member of the Board of Trustees at the University of Colorado. Vern also contributes as a TAP Board Member for The Leukemia & Lymphoma Society, Chairman of the Morris Animal Foundation, a Lecturer at the University of California, San Francisco in a Global Entrepreneurship Course, and as a member of the Board of Overseers at Scripps Research.